Cain McClary

Cain McClary MD is the founder and Managing Partner of KdT Ventures. Over the past 10 years, Cain has been at the forefront of the intersection between technology and science/medicine. He has invested in over 20 companies in the space including Zymergen, PathAI, Solugen, and Firefly Bioworks (Acquired by AbCam). Additionally, Cain is involved in entrepreneurship and finance advisory at both the local and national levels, including service on the endowments of both the US and Canadian Academy of Pathology and Black Mountain Presbyterian Church and the board of HATCH Asheville. Dr. McClary received a ScB in Biochemistry and Molecular Biology from Brown University and his MD from Tulane University. He completed his medical training as a pathologist at Stanford University where he served as Chief Resident and joined faculty there after training, becoming the youngest faculty member in the department at the time. Currently, Cain serves on the faculty at the Tulane University School of Medicine.